Mental health in myasthenia gravis patients and its impact on caregiver burden

Derin Marbin(Humboldt-Universität zu Berlin), Andreas Meisel(Humboldt-Universität zu Berlin)

Scientific Reports

November 11, 2022

10.1038/s41598-022-22078-3

Cited by 36

Related Papers

Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use

|The Lancet Neurology|2009|581

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.

|PubMed|2002|452

Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an<i>In Vitro</i>Model

|Journal of Neuroscience|2002|387

Blocking Stroke-Induced Immunodeficiency Increases CNS Antigen-Specific Autoreactivity But Does Not Worsen Functional Outcome after Experimental Stroke

|Journal of Neuroscience|2015|76

Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort

|Journal of Neurology|2024|18